Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Ani Pharmaceuticals (ANIP) over the last 14 years, with Q3 2025 value amounting to 0.07%.

  • Ani Pharmaceuticals' Return on Invested Capital rose 600.0% to 0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07%, marking a year-over-year increase of 600.0%. This contributed to the annual value of 0.0% for FY2024, which is 600.0% down from last year.
  • Latest data reveals that Ani Pharmaceuticals reported Return on Invested Capital of 0.07% as of Q3 2025, which was up 600.0% from 0.01% recorded in Q2 2025.
  • Over the past 5 years, Ani Pharmaceuticals' Return on Invested Capital peaked at 0.07% during Q3 2025, and registered a low of 0.07% during Q1 2022.
  • Its 5-year average for Return on Invested Capital is 0.0%, with a median of 0.0% in 2024.
  • In the last 5 years, Ani Pharmaceuticals' Return on Invested Capital plummeted by -600bps in 2022 and then skyrocketed by 1300bps in 2023.
  • Over the past 5 years, Ani Pharmaceuticals' Return on Invested Capital (Quarter) stood at 0.06% in 2021, then skyrocketed by 37bps to 0.04% in 2022, then skyrocketed by 250bps to 0.06% in 2023, then tumbled by -99bps to 0.0% in 2024, then skyrocketed by 11627bps to 0.07% in 2025.
  • Its Return on Invested Capital stands at 0.07% for Q3 2025, versus 0.01% for Q2 2025 and 0.01% for Q1 2025.